title: In vivo selection of moxifloxacin-resistant Clostridium difficile.
authors.forename: Ana
authors.initials: A
authors.lastname: Mena
authors.forename: Elena
authors.initials: E
authors.lastname: Riera
authors.forename: Carla
authors.initials: C
authors.lastname: López-Causapé
authors.forename: Irene
authors.initials: I
authors.lastname: Weber
authors.forename: José L
authors.initials: JL
authors.lastname: Pérez
authors.forename: Antonio
authors.initials: A
authors.lastname: Oliver
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000187:drug effects / Q000235:genetics* / Q000302:isolation & purification; D027081:DNA Gyrase / Q000235:genetics*; D024881:Drug Resistance, Bacterial / Q000235:genetics*; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy* / Q000382:microbiology; D024841:Fluoroquinolones; D006801:Humans; D007527:Isoenzymes / Q000235:genetics; D008297:Male; D008826:Microbial Sensitivity Tests; D000077266:Moxifloxacin; D009154:Mutation; D011804:Quinolines / Q000627:therapeutic use*; D017422:Sequence Analysis, DNA
chemical_list: D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D007527:Isoenzymes; D011804:Quinolines; D027081:DNA Gyrase; D000077266:Moxifloxacin